Haemonetics Corp. (HAE) Tops Q2 EPS by 13c
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.90, $0.13 better ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
